Lamotrigine
NDC 50228-322, Lamotrigine, tablet, orally disintegrating, from ScieGen Pharmaceuticals, Inc..
- Product NDC
- 50228-322
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206382
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-322 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMOTRIGINE200 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-322-01 | 50228032201 | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (50228-322-01) |
| 50228-322-30 | 50228032230 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (50228-322-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/de700ac1-4048-467e-abb1-238953261a97
Use it
Look up 50228-322 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-322 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-322. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.